Geron | GERN - Market Capitalization


Geron reported $1.15B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Amgen USD 201.45B 25.2B Feb/2026
Bio Techne USD 10.78B 1.62B Feb/2026
Cassava Sciences USD 86M 55M Feb/2026
Cytokinetics USD 8.06B 1.49B Feb/2026
Esperion Therapeutics USD 340M 235M Dec/2023
Exelixis USD 12.27B 523M Feb/2026
Genmab DKK 80.88B 7.82B Jun/2025
Geron USD 874M 24M Sep/2025
Gilead Sciences USD 183.59B 31.31B Feb/2026
Incyte USD 22.7B 3.31B Feb/2026
MacroGenics USD 114M 8M Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Novavax USD 684M 43M Sep/2023